Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in patients with pancreatic adenocarcinoma
Pancreatology · 2025-03 · 25 (2) · 258-265
DOI: 10.1016/j.pan.2025.01.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2025-03. Verfasst von Mike J P de Jong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: mike.dejong@radboudu…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Contrast Media, Endosonography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Cancer Society.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: mike.dejong@radboudumc.nl.
- Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
- Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, the Netherlands.
- Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherland…
Förderung
- Dutch Cancer Society
Zitieren
APA
de Jong, M. J. P., van Delft, F., Radstake, F. D. W., Perik, T. H., Litjens, G., Bisseling, T. M., van der Sommen, F., van Geenen, E. M., Hermans, J. J., & Siersema, P. D. (2025). Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in patients with pancreatic adenocarcinoma. Pancreatology, 25(2), 258-265. https://doi.org/10.1016/j.pan.2025.01.011
Vancouver
de Jong MJP, van Delft F, Radstake FDW, Perik TH, Litjens G, Bisseling TM, et al. Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in patients with pancreatic adenocarcinoma. Pancreatology. 2025;25(2):258-265. doi:10.1016/j.pan.2025.01.011
BibTeX
@article{deJong2025,
author = {de Jong, Mike J P and van Delft, Foke and Radstake, Fer D W and Perik, Tom H and Litjens, Geke and Bisseling, Tanya M and van der Sommen, Fons and van Geenen, Erwin-Jan M and Hermans, John J and Siersema, Peter D},
title = {Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in patients with pancreatic adenocarcinoma},
journal = {Pancreatology},
year = {2025},
volume = {25},
number = {2},
pages = {258--265},
doi = {10.1016/j.pan.2025.01.011}
}
EUVIMED